We report a seizure-related death in a patient with juvenile myoclonic epilepsy 3 months following a previous generalised tonicclonic seizure complicated by pulmonary oedema. Seizure-related pulmonary oedema is rare but may indicate an increased susceptibility to epilepsy related death. We consider possible preventative measures for patients presenting with seizure-related pulmonary oedema.
INTRODUCTION
Acute pulmonary oedema as a rare complication of a tonic-clonic seizure was first described in 1908 1 . Although pulmonary oedema is usual following sudden unexplained death in epilepsy (SUDEP) at autopsy 2, 3 , typically without pre-existing pulmonary or cardiac disease 4 , previous reports of seizurerelated pulmonary oedema have not been linked to a subsequent increased risk of sudden death. We describe a case of seizure related pulmonary oedema followed 3 months later by SUDEP, and speculate on cardiovascular medications which may have prevented this death.
CASE REPORT
An18-year-old student was admitted in May 1999 following a generalized tonic-clonic seizure. Previous episodes had occurred in 1990, 1991, 1992 and April 1999, each shortly after awakening. For several years he had had occasional absences and myoclonic jerks, especially in the mornings, and particularly following sleep deprivation or alcohol. Carbamazepine had been prescribed in 1991, and later changed to sodium valproate, but medication had been stopped in 1997. He was on no medication on this admission. There was no history of alcohol excess or illicit drug abuse. He had been born normally, but had required transfusion when aged 5 h. Two paternal first cousins had epilepsy. An electroencephalogram in 1995 had shown sub-clinical generalized spike-andwave without photosensitivity. Electrocardiogram was normal and in particular the QT interval was normal.
On this occasion, the generalized tonic-clonic seizure was associated with prolonged apnoea and cyanosis. He was intubated at home by a paramedic crew, ventilated on 100% oxygen and transferred to hospital. Chest auscultation revealed widespread fine crackles. Arterial blood gas tensions suggested alveolar hypoventilation (pH 6.96, PaO 2 90.1 mmHg, PaCO 2 47.1 mmHg) and chest radiograph showed widespread bilateral pulmonary oedema. Cranial computed tomography (CT) was normal. He was sedated, paralysed, intubated and ventilated overnight and made a rapid recovery. A diagnosis of juvenile myoclonic epilepsy was made and he was prescribed sodium valproate 500 mg twice daily. After 3 days he was discharged with plans for outpatient follow up.
In August 1999 he was readmitted having collapsed without warning. Friends witnessed a tonic-clonic seizure with cyanosis, tongue biting and incontinence and afterwards he failed to breathe and was thought to have had a cardiac arrest. He was intubated and given 5 mg of intravenous diazepam. Following several cycles of cardio-pulmonary massage, adrenaline and atropine, at home and on admission, initial asystole converted into ventricular fibrillation and was cardioverted to sinus rhythm by 200J DC shock. He was transferred in coma (Glasgow Coma Score 3) to an intensive care unit. There was mild neck stiffness, hypertension (220/70 mmHg), but normal heart rate and rhythm. Arterial blood gas tensions demonstrated acidosis and hypoxaemia (pH 6.66, PaO 2 33 mmHg, PaCO 2 11.7 mmHg) and chest radiograph again showed widespread bilateral pulmonary oedema. Cranial CT demonstrated diffuse cerebral oedema, basal ganglia low densities and associated petechial haemorrhages. His medication compliance was reported to have been satisfactory but serum sodium valproate level was sub-therapeutic at 28 mg L −1 (reference range 50-100 mg L −1 ).
Six hours after admission, brainstem function tests confirmed his death. Autopsy showed extensive cerebral oedema and infarction with a small amount of subarachnoid blood, but no arterial aneurysm. His lungs were heavily congested and oozed oedema on sectioning. A diagnosis of SUDEP was made.
DISCUSSION
SUDEP is attributed mainly to ventilatory rather than circulatory causes 5, 6 . In the case presented here, however, a seizure-provoked cardiac death is more likely. Acute neurogenic pulmonary oedema can follow any acute cerebral insult, such as severe head injury, subarachnoid haemorrhage, or an epileptic seizure. It results from a centrally mediated massive increase in sympathetic drive 7 , with intense generalized vasoconstriction and increased systemic arterial and pulmonary vascular pressure. The resulting acute pulmonary oedema is associated with pulmonary vascular injury. Its high mortality is attributable mainly to the underlying brain insult. The centrally mediated alpha adrenergic sympathetic discharge may provoke not only pulmonary oedema but also potentially malignant ventricular tachyarrhythmias increasing the associated risk of sudden death 8 . Pulmonary oedema is rare following an epileptic seizure 9 , yet is found in the majority of SUDEP cases at autopsy 2, 3 . We therefore speculate that our patient's previous seizure-related pulmonary oedema indicated a particular cardiovascular vulnerability to seizures, and that this might have prompted some intervention to prevent his subsequent epilepsy-related death.
Neurogenic pulmonary oedema is preventable in the laboratory by pre-treatment with central nervous system depressants and adrenergic blocking drugs 10, 11 . Vasodilators that decrease the systemic vascular resistance by acting directly on vessel walls or indirectly via alpha adrenoceptors have also been used with some benefit 12 . Alpha adrenergic blocking agents can suppress the effects of the centrally generated massive sympathetic discharge and so prevent both neurogenic pulmonary oedema 10, 11 and central nervous system generated cardiac arrhythmias 13 . The available data in humans relate to the acute treatment of neurogenic pulmonary oedema giving little guidance as to the choice of alpha blocker as preventative treatment. Doxasozin is currently the alpha blocker most frequently used to treat hypertension, prostatic symptoms and phaeochromocytoma, its benefits being its once daily administration and few side effects. Phentolamine and phenoxybenzamine are now rarely used in clinical practice due to their mode of administration and side effect profile. Beta blockers clearly also have an important role in preventing cardiac arrhythmias, although would not be used in the acute situation as they suppress myocardial contractility. The non selective combined alpha and beta adrenergic receptor blockers such as labetalol, carvedilol and celiprolol may prevent cardiac arrhythmias but they provide less powerful alpha blockade than the selective alpha blockers and so offer limited protection against neurogenic pulmonary oedema.
The combination of a selective alpha blocker (such as doxasozin) and a beta blocker may therefore offer the optimal prophylaxis against both neurogenic pulmonary oedema and malignant arrhythmias. Such treatment would require careful monitoring to avoid troublesome hypotension. The combination might be considered for selected patients seemingly at particular risk of the cardiovascular complications of seizures, such as those surviving an episode of seizure-related neurogenic pulmonary oedema. Whether these drugs have a wider place in preventing the cardiovascular consequences of poorly controlled but hitherto uncomplicated generalized tonic-clonic seizures is presently unclear.
We conclude that this patient was at increased risk of SUDEP, as suggested by his previous episode of seizure-related pulmonary oedema, and that subsequent prophylaxis with a selective alpha and beta blocker may have prevented his death.
